מחלה שארית מינימלית (Hebrew Wikipedia)

Analysis of information sources in references of the Wikipedia article "מחלה שארית מינימלית" in Hebrew language version.

refsWebsite
Global rank Hebrew rank
4th place
18th place
2nd place
10th place

doi.org

  • Hensel, JA; Flaig, TW; Theodorescu, D (2013). "Clinical opportunities and challenges in targeting tumour dormancy". Nature reviews. Clinical oncology. 10 (1): 41–51. doi:10.1038/nrclinonc.2012.207. PMID 23183631.
  • Maman, Shelly; Witz, Isaac P. (2013). The Tumor Immunoenvironment. p. 15. doi:10.1007/978-94-007-6217-6_2. ISBN 978-94-007-6216-9.
  • Klein-Goldberg, A; Maman, S; Witz, IP (2013). "The role played by the microenvironment in site-specific metastasis". Cancer letters. doi:10.1016/j.canlet.2013.08.029. PMID 23988268.
  • Maman, S; Edry-Botzer, L; Sagi-Assif, O; Meshel, T; Yuan, W; Lu, W; Witz, IP (2013). "The metastatic microenvironment: Lung-derived factors control the viability of neuroblastoma lung metastasis". International journal of cancer. Journal international du cancer. 133 (10): 2296–306. doi:10.1002/ijc.28255. PMID 23649556.
  • Schrappe, M (2012). "Minimal residual disease: Optimal methods, timing, and clinical relevance for an individual patient". Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2012: 137–42. doi:10.1182/asheducation-2012.1.137. PMID 23233572.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Arvelo, F (2013). "Micrometastases: Strategies for detection". Investigacion clinica. 54 (2): 206–25. PMID 23947009.
  • Hensel, JA; Flaig, TW; Theodorescu, D (2013). "Clinical opportunities and challenges in targeting tumour dormancy". Nature reviews. Clinical oncology. 10 (1): 41–51. doi:10.1038/nrclinonc.2012.207. PMID 23183631.
  • Yu, Y; Zhu, Z (2013). "Cell dormancy and tumor refractory". Anti-cancer agents in medicinal chemistry. 13 (2): 199–202. PMID 22934702.
  • Klein-Goldberg, A; Maman, S; Witz, IP (2013). "The role played by the microenvironment in site-specific metastasis". Cancer letters. doi:10.1016/j.canlet.2013.08.029. PMID 23988268.
  • Maman, S; Edry-Botzer, L; Sagi-Assif, O; Meshel, T; Yuan, W; Lu, W; Witz, IP (2013). "The metastatic microenvironment: Lung-derived factors control the viability of neuroblastoma lung metastasis". International journal of cancer. Journal international du cancer. 133 (10): 2296–306. doi:10.1002/ijc.28255. PMID 23649556.
  • Iinuma, H; Watanabe, T (2012). "Development of minimal residual cancer cell research". Nihon Geka Gakkai zasshi. 113 (2): 177–84. PMID 22582577.
  • Schrappe, M (2012). "Minimal residual disease: Optimal methods, timing, and clinical relevance for an individual patient". Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2012: 137–42. doi:10.1182/asheducation-2012.1.137. PMID 23233572.